CICON

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to join forces to…

Adding to his already quite impressive list of honors and awards, the Lasker Foundation announced today that James P. Allison, Ph.D., director of CRI’s Scientific Advisory Council, is the 2015 winner of the prestigious…

This week, beginning on Wednesday, the Cancer Research Institute (CRI) will be teaming up with three other cancer organizations to co-host an international scientific meeting devoted to cancer immunotherapy. Entitled…

Times Square in Manhattan today was home to a different sort of blockbuster show, as 1,400 of the world’s most talented immunologists converged on the Big Apple for the inaugural International Cancer Immunotherapy…

Every year for the past 40 years, the Cancer Research Institute (CRI) has given an award to scientists in honor of the late William B. Coley, M.D., considered the Father of Cancer Immunotherapy. It’s become a tradition…

Today’s sessions at the inaugural International Cancer Immunotherapy Conference focused on four main areas: viruses and cancer; biomarkers; imaging immune responses; and the microbiome. I won’t be able to report on all…

Much of this conference has focused on using immunotherapy to treat cancer. Today, we heard from several investigators who are working on the other end of the equation: developing ways to prevent cancer. This includes…

Whoever said science and politics don’t mix wasn’t at the 29th annual awards dinner of the Cancer Research Institute (CRI), held last Thursday night at the Metropolitan Club in Manhattan. Former President Bill Clinton…

Despite the availability of an effective preventive vaccine for the human papillomavirus (HPV), the virus that causes cervical cancer, many girls do not receive this vaccine and go on to contract HPV when they become…

This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New York City, for the second International Cancer Immunotherapy Conference (CICON). The conference is being hosted…

Antigen is a term you might never have heard before, but chances are that if we ever cure cancer, it will be because we learned how to take advantage of these important molecules. There’s a reason that Day 1 of the…

Checkpoint inhibitors have produced amazing responses against several types of cancer; however, many cancers are resistant to current checkpoint inhibitors and a significant percentage of patients do not respond. The…

Cancer is incredibly difficult to treat because it’s not just cancer cells we’re up against. It’s the cancer cells, plus all the other non-cancer cells, including some immune cells, that the tumor has corrupted and…

Following up on our previous post from the CRI-CIMT-EATI-AACR Second International Cancer Immunotherapy Conference in New York City, which covered the tumor microenvironment, we now turn to the another important factor…

On Day 3 of CICON16, the name of the game was combinations. Single treatments work against some cancers, especially if they’re caught early, but they’re often ineffective against advanced tumors. Moving forward, experts…

The Second International Cancer Immunotherapy Conference (CICON16), themed Translating Science Into Survival, explored a wide range of immunotherapy strategies that are grounded in science and improving patients’ lives.…